Cargando…

Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck

Immunotherapies such as immune checkpoint blockade benefit only a portion of patients with head and neck squamous cell carcinoma. The multidisciplinary field of nanomedicine is emerging as a promising strategy to achieve maximal anti-tumor effect in cancer immunotherapy and to turn non-responders in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Qiang, Fang, Meiyu, Zhu, Jing, Dong, Haoru, Cao, Jun, Yan, Lin, Leonard, Fransisca, Oppel, Felix, Sudhoff, Holger, Kaufmann, Andreas M., Albers, Andreas E., Qian, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415431/ https://www.ncbi.nlm.nih.gov/pubmed/32792853 http://dx.doi.org/10.7150/ijbs.47068

Ejemplares similares

An Effective Primary Head and Neck Squamous Cell Carcinoma In Vitro Model
por: Oppel, Felix, et al.
Publicado: (2019)

Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer
por: Xu, Qiang, et al.
Publicado: (2022)

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts
por: Yao, Wenhao, et al.
Publicado: (2021)

Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care
por: Dong, Haoru, et al.
Publicado: (2021)

Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma
por: Bann, Darrin V., et al.
Publicado: (2016)

Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment
por: Viegas, Cláudia, et al.
Publicado: (2022)

Viral and Clinical Oncology of Head and Neck Cancers
por: Goon, Peter, et al.
Publicado: (2022)

Prognostic Score Predicts Survival in HPV-Negative Head and Neck Squamous Cell Cancer Patients
por: Qian, Xu, et al.
Publicado: (2019)

Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
por: Chen, Chao, et al.
Publicado: (2011)

A Quest for Initiating Cells of Head and Neck Cancer and Their Treatment
por: Chen, Chao, et al.
Publicado: (2010)

The Potential of Tumor Debulking to Support Molecular Targeted Therapies
por: Oppel, Felix, et al.
Publicado: (2020)

Sensorineural Hearing Loss After Balloon Eustachian Tube Dilatation
por: Todt, Ingo, et al.
Publicado: (2021)

BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma
por: Pan, Xue, et al.
Publicado: (2023)

A bibliometric analysis on studies of nanomedicine applications in head and neck squamous cell carcinoma
por: Gao, Xiaolan, et al.
Publicado: (2021)

Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects
por: Gao, Lei, et al.
Publicado: (2022)

Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment
por: Bhattacharjee, Bedanta, et al.
Publicado: (2023)

Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer
por: Saba, Nabil F., et al.
Publicado: (2023)

Current clinical immunotherapeutic approaches for head and neck cancer
por: Soto Chervin, Carolina, et al.
Publicado: (2016)

Taxane-cisplatin-fluorouracil as induction chemotherapy for advanced head and neck cancer: a meta-analysis of the 5-year efficacy and safety
por: Qian, Xu, et al.
Publicado: (2015)

Molecular targeted therapies in head and neck cancer - An update of recent developements -
por: Goerner, Martin, et al.
Publicado: (2010)

The immunotherapeutic role of indoleamine 2,3‐dioxygenase in head and neck squamous cell carcinoma: A systematic review
por: Lin, Daniel J., et al.
Publicado: (2021)

Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis
por: Dong, Yue, et al.
Publicado: (2017)

PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma
por: Wang, Libo, et al.
Publicado: (2023)

Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer
por: Albers, Andreas E., et al.
Publicado: (2018)

Nanomedicine-mediated alteration of the pharmacokinetic profile of small molecule cancer immunotherapeutics
por: Van Herck, Simon, et al.
Publicado: (2020)

Identification of Immune-Related LncRNA Pairs for Predicting Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma
por: Wang, Xueying, et al.
Publicado: (2021)

Molecular Subtypes Based on Cell Differentiation Trajectories in Head and Neck Squamous Cell Carcinoma: Differential Prognosis and Immunotherapeutic Responses
por: Huang, Zhen-Dong, et al.
Publicado: (2021)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes
por: Shao, Senyao, et al.
Publicado: (2023)

CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma
por: Wei, Zhengyu, et al.
Publicado: (2022)

Vascular mimicry in cultured head and neck tumour cell lines
por: Upile, Tahwinder, et al.
Publicado: (2011)

The Therapeutic Effect of 1,8-Cineol on Pathogenic Bacteria Species Present in Chronic Rhinosinusitis
por: Schürmann, Matthias, et al.
Publicado: (2019)

Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy
por: Chen, Shanshan, et al.
Publicado: (2023)

T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
por: Albers, A. E., et al.
Publicado: (2010)

The genes regulating sensitivity of tumor cells to T cell-mediated killing: could they be potential personalized immunotherapeutic targets in head and neck squamous cell carcinoma?
por: Hu, Shaonan, et al.
Publicado: (2023)

Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma
por: Gaykalova, Daria A., et al.
Publicado: (2014)

HPV & head and neck cancer: a descriptive update
por: Goon, Peter KC, et al.
Publicado: (2009)

Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
por: Gabizon, Alberto, et al.
Publicado: (2023)

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer
por: Klinghammer, Konrad, et al.
Publicado: (2020)

Role of Epstein–Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target
por: Fernandes, Queenie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i4k72p62m5elib3bce9nld7s85